Jump to content

Hydroxycarbamide: Revision history


For any version listed below, click on its date to view it. For more help, see Help:Page history and Help:Edit summary. (cur) = difference from current version, (prev) = difference from preceding version, m = minor edit, → = section edit, ← = automatic edit summary

(newest | oldest) View (newer 50 | ) (20 | 50 | 100 | 250 | 500)

24 July 2024

10 July 2024

9 July 2024

  • curprev 12:3212:32, 9 July 2024Mervindv talk contribs 20,169 bytes +272 Systemic mastocytocis was under the indications of Hydroxyurea, however mastocytosis specifically is no indication for this medication but rather associated hematological neoplasm sometimes seen in patiënts with systemic mastocytosis. I have added this nuance to the text and added a link to the mast cell page and added a better citation to a article published in the american journal of hematology. undo Tag: Visual edit

14 June 2024

18 May 2024

20 March 2024

13 March 2024

16 February 2024

19 December 2023

11 December 2023

2 December 2023

11 August 2023

7 May 2023

24 April 2023

3 February 2023

22 October 2022

19 October 2022

12 June 2022

29 April 2022

12 February 2022

30 January 2022

6 January 2022

16 October 2021

11 October 2021

13 September 2021

22 June 2021

30 January 2021

14 January 2021

7 January 2021

2 December 2020

14 October 2020

27 September 2020

27 August 2020

1 August 2020

23 July 2020

1 July 2020

30 June 2020

14 June 2020

(newest | oldest) View (newer 50 | ) (20 | 50 | 100 | 250 | 500)